Postdoctoral Scientist in Tumor Immunology González-Suárez Lab in the Cancer Epigenetics and Biology Program

Job type: 
Postdoctoral Fellow
Date Posted: 
Monday, December 19, 2016

Bellvitge Institute for Biomedical Research (IDIBELL) offers a postdoctoral contract to join the Transformation and Metastasis group led by Dr. Eva González-Suárez within the Cancer Epigenetics and Biology Program (PEBC)
http://www.idibell.cat/modul/transformacio-i-metastasi/cat
http://pebc.cat/
The laboratory of Dr Gonzalez Suarez is funded by the Susan G Komen Foundation and a European Research Council ERC-Consolidator grant. The candidate will join a project focused on understanding tumor-immune crosstalk in epithelial tumors.
The primary goal of Dr. Eva González-Suárez ́s laboratory is to understand the signaling pathways implicated in epithelial stem cell fate, their alterations during cancer    and    metastasis,   and   the interactions between tumor cells and microenvironment. We have a multidisciplinary approach using mouse models, cell cultures, clinical samples and molecular and cell biology techniques to translate basic research into clinically relevant results.
REQUIREMENTS
We are looking for motivated postdoctoral scientists holding a PhD in a relevant discipline with interest in cancer biology. Candidates must have: - An outstanding publication record in peer review journals. - Experience working with mouse models of cancer and patient derived xenografts.
- Strong technical skills in tumor immunology, molecular biology and lineage tracing.
WE OFFER
• The opportunity to contribute to cutting-edge research projects and work closely with an international team of scientists and work in one of the leading labs in Europe.
• A 3-year full time contract, immediate start. Renewal based on performance.

Contact Info: 

Applications must include a CV with a cover letter and contacts for 2 references

• Please apply by email to:

egsuarez@idibell.cat

Please, clearly state in the subject of your email “Postdoc Position” and a link to your most outstanding publication.

Application Deadline: 
Sunday, December 31, 2017
Position open until filled